{
  "author": {
    "name": "Peter B Bach",
    "webUrl": "/author/profile/peter-b-bach/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 2,
    "social": [],
    "articles": [
      {
        "uri": "/2019/10/31/nancy-pelosi-calls-pharmas-bluff-on-drug-prices/",
        "title": "Nancy Pelosi calls pharma's bluff on drug prices",
        "byline": "Peter B. Bach",
        "kicker": "Commentary",
        "prettyDate": "October 31, 2019",
        "timeToRead": "4 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2019/05/PillsCoinsShutterstock.jpg",
          "width": "616",
          "height": "372"
        },
        "authors": [
          {
            "webUrl": "/author/profile/peter-b-bach/",
            "name": "Peter B. Bach"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "Pelosi's plan is to finally use the market power of Medicare, the largest purchaser of drugs in the world, to push prices down.",
        "body": null
      },
      {
        "uri": "/2018/05/02/medicaid-is-right-to-demand-lower-drug-prices/",
        "title": "Medicaid is right to demand lower drug prices",
        "byline": "Peter B. Bach",
        "kicker": "Commentary",
        "prettyDate": "May 02, 2018",
        "timeToRead": "5 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/04/risinghealthcosts-crop-600x338.jpg",
          "width": "600",
          "height": "338"
        },
        "authors": [
          {
            "webUrl": "/author/profile/peter-b-bach/",
            "name": "Peter B. Bach"
          }
        ],
        "kickerNode": [
          {
            "uri": "/commentary/",
            "sectionName": "Commentary"
          }
        ],
        "summary": "Manufacturers argue that market competition is enough to keep drug prices under control, but many drugs have no competitors.",
        "body": null
      }
    ]
  }
}